These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Arai T; Nonaka T; Hasegawa M; Akiyama H; Yoshida M; Hashizume Y; Tsuchiya K; Oda T; Ikeda K Neurosci Lett; 2003 May; 342(1-2):41-4. PubMed ID: 12727313 [TBL] [Abstract][Full Text] [Related]
9. Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke Family 1684. Hulette CM; Pericak-Vance MA; Roses AD; Schmechel DE; Yamaoka LH; Gaskell PC; Welsh-Bohmer KA; Crowther RA; Spillantini MG J Neuropathol Exp Neurol; 1999 Aug; 58(8):859-66. PubMed ID: 10446810 [TBL] [Abstract][Full Text] [Related]
10. Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. Mackenzie IR; Feldman HH J Neuropathol Exp Neurol; 2005 Aug; 64(8):730-9. PubMed ID: 16106222 [TBL] [Abstract][Full Text] [Related]
11. Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study. Kövari E; Gold G; Giannakopoulos P; Bouras C Acta Neuropathol; 2004 Sep; 108(3):207-12. PubMed ID: 15170577 [TBL] [Abstract][Full Text] [Related]
12. Neuronal ubiquitinated intranuclear inclusions in familial and non-familial frontotemporal dementia of the motor neuron disease type associated with amyotrophic lateral sclerosis. Bigio EH; Johnson NA; Rademaker AW; Fung BB; Mesulam MM; Siddique N; Dellefave L; Caliendo J; Freeman S; Siddique T J Neuropathol Exp Neurol; 2004 Aug; 63(8):801-11. PubMed ID: 15330335 [TBL] [Abstract][Full Text] [Related]
13. Neuronal ultrastructural abnormalities in a patient with frontotemporal dementia and motor neuron disease. Chang L; Cornford M; Miller BL; Itabashi H; Mena I Dementia; 1995; 6(1):1-8. PubMed ID: 7728214 [TBL] [Abstract][Full Text] [Related]
14. Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method. Yang Y; Schmitt HP Acta Neuropathol; 2001 Mar; 101(3):256-70. PubMed ID: 11307626 [TBL] [Abstract][Full Text] [Related]
15. The new neuropathology of degenerative frontotemporal dementias. Jackson M; Lowe J Acta Neuropathol; 1996; 91(2):127-34. PubMed ID: 8787144 [TBL] [Abstract][Full Text] [Related]
16. Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study. Bergmann M; Kuchelmeister K; Schmid KW; Kretzschmar HA; Schröder R Acta Neuropathol; 1996 Aug; 92(2):170-9. PubMed ID: 8841663 [TBL] [Abstract][Full Text] [Related]
17. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Kersaitis C; Halliday GM; Kril JJ Acta Neuropathol; 2004 Dec; 108(6):515-23. PubMed ID: 15368070 [TBL] [Abstract][Full Text] [Related]
18. The genetic and pathological classification of familial frontotemporal dementia. Morris HR; Khan MN; Janssen JC; Brown JM; Perez-Tur J; Baker M; Ozansoy M; Hardy J; Hutton M; Wood NW; Lees AJ; Revesz T; Lantos P; Rossor MN Arch Neurol; 2001 Nov; 58(11):1813-6. PubMed ID: 11708988 [TBL] [Abstract][Full Text] [Related]